Unaudited Condensed Consolidated Statements of Stockholders’ Equity - USD ($) $ in Thousands	Total	Total Stockholders’ Equity (Deficit) Attributable to the Company	Preferred Stock	Additional Paid-in Capital	Accumulated Other Comprehensive Income (Loss)	Accumulated Deficit	Noncontrolling Interests	Class A Common Stock Common Stock	Class B Common Stock Common Stock
Beginning balance (in shares) at Dec. 31, 2023								1,060,833	6,667
Beginning balance at Dec. 31, 2023	$ 228,236			$ 4,180,873	$ 5,862	$ (3,958,499)		$ 0	$ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Conversion of notes payable and accrued interest into Class A Common Stock (in shares)								29,077,806
Conversion of notes payable and accrued interest into Class A Common Stock	159,906			159,903				$ 3
Reclassification of SPA Warrants from liability to equity	160			160
Issuance of common stock and warrants	10			10
Settlements with issuance of Class A Common Stock (in shares)								252,768
Settlements with issuance of Class A Common Stock	2,400			2,400
Purchase of Class A Common Stock under Salary Deduction and Stock Purchase Agreements (in shares)								10,455
Purchase of Class A Common Stock under Salary Deduction and Stock Purchase Agreements	36			36
Reverse stock split related round up share issuances (in shares)								306,779
Stock-based compensation	2,252			2,252
Issuance of shares for RSU vesting net of tax withholdings (in shares)								5,088
Issuance of shares for RSU vesting net of tax withholdings	(10)			(10)
Foreign currency translation adjustment	(1,646)				(1,646)
Net loss	(234,588)					(234,588)
Ending balance (in shares) at Sep. 30, 2024								30,713,729	6,667
Ending balance at Sep. 30, 2024	156,756			4,345,624	4,216	(4,193,087)		$ 3	$ 0
Beginning balance (in shares) at Jun. 30, 2024								11,031,625	6,667
Beginning balance at Jun. 30, 2024	148,682			4,257,356	6,726	(4,115,401)		$ 1	$ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Conversion of notes payable and accrued interest into Class A Common Stock (in shares)								19,107,321
Conversion of notes payable and accrued interest into Class A Common Stock	84,081			84,079				$ 2
Reclassification of SPA Warrants from liability to equity	160
Issuance of common stock and warrants	10
Settlements with issuance of Class A Common Stock (in shares)								252,768
Settlements with issuance of Class A Common Stock	2,400
Purchase of Class A Common Stock under Salary Deduction and Stock Purchase Agreements (in shares)								10,455
Purchase of Class A Common Stock under Salary Deduction and Stock Purchase Agreements	36
Reverse stock split related round up share issuances (in shares)								306,472
Stock-based compensation	1,593			1,593
Issuance of shares for RSU vesting net of tax withholdings (in shares)								5,088
Issuance of shares for RSU vesting net of tax withholdings	(10)
Foreign currency translation adjustment	(2,510)				(2,510)
Net loss	(77,686)					(77,686)
Ending balance (in shares) at Sep. 30, 2024								30,713,729	6,667
Ending balance at Sep. 30, 2024	156,756			4,345,624	4,216	(4,193,087)		$ 3	$ 0
Beginning balance (in shares) at Dec. 31, 2024			0					65,919,127	6,667
Beginning balance at Dec. 31, 2024	114,967	$ 114,967	$ 0	4,421,563	7,744	(4,314,346)	$ 0	$ 6	$ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Conversion of notes payable and accrued interest into Class A Common Stock (in shares)			(3,983,897)					86,028,126
Conversion of notes payable and accrued interest into Class A Common Stock	145,275	145,275		145,266				$ 9
Reclassification of SPA warrants from liability to equity (in shares)			14,720,914
Issuance of Common Stock and warrants	1	1		1
Settlements with issuance of Class A Common Stock (in shares)								1,591,035
Settlements with issuance of Class A Common Stock	2,245	2,245		2,245
Related party debt restructuring	3,767	3,767		3,767
Stock-based compensation	536	536		536
Exercise of warrants (in shares)								7,516,026
Exercise of warrants	14,090	14,090		14,089				$ 1
Issuance of shares for RSU vesting net of tax withholdings (in shares)								251,212
Issuance of shares for RSU vesting net of tax withholdings	74	74		74
Foreign currency translation adjustment	(1,558)	(1,558)			(1,558)
Net loss	(357,141)	(357,141)				(357,141)
Noncontrolling interest	38,204						38,204
Ending balance (in shares) at Sep. 30, 2025			10,737,017					161,305,526	6,667
Ending balance at Sep. 30, 2025	(39,540)	(77,744)	$ 0	4,587,541	6,186	(4,671,487)	38,204	$ 16	$ 0
Beginning balance (in shares) at Jun. 30, 2025			4,400,232					122,722,249	6,667
Beginning balance at Jun. 30, 2025	59,856	59,856	$ 0	4,501,989	7,155	(4,449,300)	0	$ 12	$ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Conversion of notes payable and accrued interest into Class A Common Stock (in shares)			(2,031,268)					30,945,927
Conversion of notes payable and accrued interest into Class A Common Stock	68,285	68,285		68,282				$ 3
Issuance of preferred stock series B to SPA noteholders (in shares)			8,368,053
Issuance of Common Stock and warrants	1	1		1
Related party debt restructuring	(3,113)	(3,113)		(3,113)
Stock-based compensation	67	67		67
Exercise of warrants (in shares)								7,516,026
Exercise of warrants	14,090	14,090		14,089				$ 1
Issuance of shares for RSU vesting net of tax withholdings (in shares)								121,324
Foreign currency translation adjustment	(969)	(969)			(969)
Net loss	(222,187)	(222,187)				(222,187)
Noncontrolling interest	38,204						38,204
Ending balance (in shares) at Sep. 30, 2025			10,737,017					161,305,526	6,667
Ending balance at Sep. 30, 2025	$ (39,540)	$ (77,744)	$ 0	$ 4,587,541	$ 6,186	$ (4,671,487)	$ 38,204	$ 16	$ 0